ASMB Q1 2026 Earnings Narrower Loss Surprises Market Shares Jump 694 Actinium Pharmaceuticals ATNM Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Advances Continue CVBF Q1 2026 Earnings Modest EPS Miss Amid Stable Operating Environment MXC Q3 2025 Earnings Profitability Remains Solid Amid Quiet Quarter ALLT Q1 2026 Earnings EPS Surpasses Estimates by 3575 Despite Flat Stock Response SEE Q4 2025 Earnings EPS Surpasses Expectations Amid Modest Stock Response